{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:20:02Z","timestamp":1791188402446,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1826,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>The cannabinoid receptor 2 (CB2) plays a pleiotropic role in innate immunity and is a crucial mediator of liver disease. In this study, we investigated the impact of CB2 receptors on the regenerative process associated with liver injury. Following acute hepatitis induced by carbon tetrachloride (CCl4), CB2 was induced in the nonparenchymal cell fraction and remained undetectable in hepatocytes. Administration of CCl4 to CB2\u2212\/\u2212 mice accelerated liver injury, as shown by increased alanine\/aspartate aminotransferase levels and hepatocyte apoptosis, and delayed liver regeneration, as reflected by a retarded induction of hepatocyte proliferating cell nuclear antigen expression; proliferating cell nuclear antigen induction was also delayed in CB2\u2212\/\u2212 mice undergoing partial hepatectomy. Conversely, following treatment with the CB2 agonist JWH-133, CCl4-treated WT mice displayed reduced liver injury and accelerated liver regeneration. The CCl4-treated CB2\u2212\/\u2212 mice showed a decrease in inducible nitric oxide synthase and tumor necrosis factor-\u03b1 expression, and administration of the nitric oxide donor moldomine (SIN-1) to these animals reduced hepatocyte apoptosis, without affecting liver regeneration. Impaired liver regeneration was consecutive to an interleukin-6 (IL-6)-mediated decrease in matrix metalloproteinase 2 (MMP-2) activity. Indeed, CCl4-treated CB2\u2212\/\u2212 mice displayed lower levels of hepatic IL-6 messenger RNA and increased MMP-2 activity. Administration of IL-6 to these mice decreased MMP-2 activity and improved liver regeneration, without affecting hepatocyte apoptosis. Accordingly, administration of the MMP inhibitor CTTHWGFTLC to CCl4-treated CB2\u2212\/\u2212 mice improved liver regeneration. Finally,<\/jats:bold>\n                                 <jats:bold>\n                                    in vitro\n                                 <\/jats:bold>\n                                 <jats:bold>studies demonstrated that incubation of hepatic myofibroblasts with JWH-133 increased tumor necrosis factor-\u03b1 and IL-6 and decreased MMP-2 expressions.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>CB2 receptors reduce liver injury and promote liver regeneration following acute insult, via distinct paracrine mechanisms involving hepatic myofibroblasts. These results suggest that CB2 agonists display potent hepatoprotective properties, in addition to their antifibrogenic effects.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23779","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T02:35:08Z","timestamp":1274927708000},"page":"1046-1059","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":98,"title":["Beneficial Paracrine Effects of Cannabinoid Receptor 2 on Liver Injury and Regeneration\u2020"],"prefix":"10.1097","volume":"52","author":[{"given":"Fatima","family":"Teixeira-Clerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Manin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Deveaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cadoudal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Noele","family":"Chobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Louvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Tordjmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Mallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lotersztajn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20250312","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1152\/ajpgi.00467.2007","article-title":"Endocannabinoids and their receptors in the liver.","volume":"294","author":"Mallat","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R2-27-20250312","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy.","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"R3-27-20250312","doi-asserted-by":"crossref","first-page":"e5844","DOI":"10.1371\/journal.pone.0005844","article-title":"Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.","volume":"4","author":"Deveaux","year":"2009","journal-title":"Plos One"},{"key":"R4-27-20250312","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.bjp.0707511","article-title":"CB2 receptors as new therapeutic targets during liver diseases.","volume":"153","author":"Lotersztajn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R5-27-20250312","first-page":"782","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.","volume":"434","author":"Steffens","year":"2005","journal-title":"Nat Med"},{"key":"R6-27-20250312","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1096\/fj.06-7451com","article-title":"Cannabinoid-2 receptor mediates protection against hepatic ischemiareperfusion injury.","volume":"21","author":"Batkai","year":"2007","journal-title":"FASEB J"},{"key":"R7-27-20250312","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass.","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-27-20250312","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1096\/fj.09-129478","article-title":"The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemiareperfusion-induced cardiomyopathy.","volume":"23","author":"Defer","year":"2009","journal-title":"FASEB J"},{"key":"R9-27-20250312","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/14728222.11.3.403","article-title":"Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases.","volume":"11","author":"Mallat","year":"2007","journal-title":"Expert Opin Ther Targets"},{"key":"R10-27-20250312","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a novel strategy for the treatment of liver fibrosis.","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat Med"},{"key":"R11-27-20250312","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.20733","article-title":"Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C.","volume":"42","author":"Hezode","year":"2005","journal-title":"Hepatology"},{"key":"R12-27-20250312","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","article-title":"Paracrine activation of hepatic CB(1) receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.","volume":"7","author":"Jeong","year":"2008","journal-title":"Cell Metab"},{"key":"R13-27-20250312","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB(1) receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"R14-27-20250312","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2007.11.039","article-title":"Daily cannabis use, a novel risk factor of steatosis severity in patients with chronic hepatitis C.","volume":"134","author":"Hezode","year":"2008","journal-title":"Gastroenterology"},{"key":"R15-27-20250312","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.","volume":"7","author":"Batkai","year":"2001","journal-title":"Nat Med"},{"key":"R16-27-20250312","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"key":"R17-27-20250312","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","article-title":"Antifibrogenic role of the cannabinoid receptor CB2 in the liver.","volume":"128","author":"Julien","year":"2005","journal-title":"Gastroenterology"},{"key":"R18-27-20250312","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.107.131896","article-title":"Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.","volume":"324","author":"Munoz-Luque","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R19-27-20250312","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.108.047035","article-title":"Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.","volume":"74","author":"Hegde","year":"2008","journal-title":"Mol Pharmacol"},{"key":"R20-27-20250312","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R21-27-20250312","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1096\/fj.06-6889com","article-title":"The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing.","volume":"21","author":"Serriere-Lanneau","year":"2007","journal-title":"FASEB J"},{"key":"R22-27-20250312","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2006.08.014","article-title":"Remodelling of calcium signalling during liver regeneration in the rat.","volume":"46","author":"Nicou","year":"2007","journal-title":"J Hepatol"},{"key":"R23-27-20250312","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0016-5085(03)00906-5","article-title":"Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts.","volume":"125","author":"Li","year":"2003","journal-title":"Gastroenterology"},{"key":"R24-27-20250312","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrm1489","article-title":"Liver regeneration: from myth to mechanism.","volume":"5","author":"Taub","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R25-27-20250312","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.20969","article-title":"Liver regeneration.","volume":"43","author":"Fausto","year":"2006","journal-title":"Hepatology"},{"key":"R26-27-20250312","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/taap.2000.9133","article-title":"Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice.","volume":"172","author":"Morio","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"R27-27-20250312","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/hep.22278","article-title":"Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.","volume":"47","author":"Aram","year":"2008","journal-title":"Hepatology"},{"key":"R28-27-20250312","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1073\/pnas.95.23.13829","article-title":"Impaired liver regeneration in inducible nitric oxide synthase-deficient mice.","volume":"95","author":"Rai","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-27-20250312","doi-asserted-by":"crossref","first-page":"31138","DOI":"10.1074\/jbc.272.49.31138","article-title":"Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms.","volume":"272","author":"Kim","year":"1997","journal-title":"J Biol Chem"},{"key":"R30-27-20250312","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcp.21172","article-title":"Liver regeneration.","volume":"213","author":"Michalopoulos","year":"2007","journal-title":"J Cell Physiol"},{"key":"R31-27-20250312","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2004.11.043","article-title":"Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.","volume":"42","author":"Bansal","year":"2005","journal-title":"J Hepatol"},{"key":"R32-27-20250312","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev.pharmtox.45.120403.095906","article-title":"Hepatic fibrosis: molecular mechanisms and drug targets.","volume":"45","author":"Lotersztajn","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R33-27-20250312","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1096\/fj.06-7717com","article-title":"The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species.","volume":"21","author":"Siegmund","year":"2007","journal-title":"FASEB J"},{"key":"R34-27-20250312","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1111\/j.1572-0241.2008.02155.x","article-title":"Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice.","volume":"103","author":"Avraham","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R35-27-20250312","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510310123","article-title":"Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice.","volume":"31","author":"Kovalovich","year":"2000","journal-title":"Hepatology"},{"key":"R36-27-20250312","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.alcohol.2004.07.006","article-title":"Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure.","volume":"34","author":"Gao","year":"2004","journal-title":"Alcohol"},{"key":"R37-27-20250312","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1478-3231.2006.01366.x","article-title":"Intracellular survival pathways in the liver.","volume":"26","author":"Luedde","year":"2006","journal-title":"Liver Int"},{"key":"R38-27-20250312","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.21087","article-title":"Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair.","volume":"43","author":"Jin","year":"2006","journal-title":"Hepatology"},{"key":"R39-27-20250312","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1126\/science.1137603","article-title":"Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR.","volume":"315","author":"Passino","year":"2007","journal-title":"Science"},{"key":"R40-27-20250312","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/jhep.2003.50005","article-title":"Foxf1 mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury.","volume":"37","author":"Kalinichenko","year":"2003","journal-title":"Hepatology"},{"key":"R41-27-20250312","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/gut.2003.024505","article-title":"Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.","volume":"54","author":"Sanz","year":"2005","journal-title":"Gut"},{"key":"R42-27-20250312","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0002-9440(10)64994-2","article-title":"Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation.","volume":"156","author":"Trim","year":"2000","journal-title":"Am J Pathol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23779","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201009000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:01:56Z","timestamp":1741777316000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201009000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23779","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}